Immuno-oncology digests: The Power of Innate Immune Cells to Improve Cancer Immunotherapies

In this webinar, Dr Julian Ashby will be:
– Deep diving into Natural Killer (NK) cell biology and therapies
– Evaluating the advantages of allogeneic cell therapies
– Highlighting Cell Avidity as a key indicator of therapeutic performance for NK, CAR-NK, gamma delta T cells and macrophages

Speaker
Dr. Julian Ashby, Field Application Scientist from LUMICKS